Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 94,603 | 91,730 | 66,018 | 32,657 | 0 |
| Cost of Goods | 1,198 | 863 | 1,141 | 696 | N/A |
| Gross Profit | 93,405 | 90,867 | 64,877 | 31,961 | N/A |
| Operating Expenses | 62,325 | 52,153 | 42,913 | 39,182 | 45,743 |
| Operating Income | 31,278 | 39,577 | 22,105 | -6,525 | -45,743 |
| Interest Expense | 1,292 | 1,349 | 1,390 | 1,376 | 1,361 |
| Other Income | 4,927 | 5,130 | 5,298 | 3,193 | 3,331 |
| Pre-tax Income | 34,913 | 43,358 | 26,013 | -4,708 | -43,773 |
| Income Tax | 3,535 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 31,378 | 43,358 | 26,013 | -4,708 | -43,773 |
| Net Income | $31,378 | $43,358 | $26,013 | $-4,708 | $-43,773 |
| EPS Basic Total Ops | 0.60 | 0.95 | 0.49 | -0.09 | -0.95 |
| EPS Basic Continuous Ops | 0.60 | 0.96 | 0.49 | -0.09 | -0.95 |
| EPS Diluted Total Ops | 0.59 | 0.96 | 0.47 | -0.09 | -0.95 |
| EPS Diluted Continuous Ops | 0.59 | 0.97 | 0.47 | -0.09 | -0.95 |
| EPS Diluted Before Non-Recurring Items | 0.59 | 0.80 | 0.47 | -0.09 | -0.95 |
| EBITDA(a) | $31,800 | $40,095 | $22,616 | $-6,014 | $-45,231 |